Companies
/
Modernizing Medicine
Healthtech
Modernizing Medicine is a Florida-based healthcare technology company providing specialty-specific electronic health record and practice management software for outpatient medical practices such as dermatology and ophthalmology.
Create an account to view live offerings, pricing, and market activity.
Sign in to view offerings and live market activity.
Modernizing Medicine was founded in 2010 by Daniel Cane and Dr. Michael Sherling, based on the observation that most electronic health record (EHR) systems were built as broad, general-purpose platforms intended to serve virtually any medical specialty, resulting in software that often required extensive customization or produced clunky, inefficient workflows for physicians in specialties with distinctive documentation needs, such as dermatology, which involves extensive visual documentation of skin conditions, or ophthalmology, which requires specialized diagrams and measurements not well suited to generic EHR templates designed to accommodate any medical specialty equally. The company's platform, marketed under the EMA brand, provides electronic health record systems built specifically around the particular clinical workflows, documentation templates, and terminology used within specific medical specialties, initially focusing on dermatology before expanding to cover ophthalmology, gastroenterology, orthopedics, plastic surgery, and several other specialties, each with tailored templates and workflows designed to more closely match how physicians in that specific specialty actually document patient visits, in contrast to generic EHR systems that require physicians to adapt their documentation to a template not specifically designed around their specialty's particular clinical needs. Modernizing Medicine has argued that this specialty-specific approach can meaningfully improve physician efficiency and reduce the administrative documentation burden that has been widely cited as a significant contributor to physician burnout, since specialty-tailored templates and workflows require less manual adaptation and free-text documentation than generic EHR systems not designed with a specific specialty's particular clinical patterns in mind. The company has expanded beyond core EHR functionality into broader practice management software covering scheduling, billing, and revenue cycle management for the specialty practices it serves. Modernizing Medicine's customers span independent specialty medical practices across the specialties it has built tailored software for. The company has raised substantial private equity and venture funding, reaching a valuation exceeding $5.3 billion, competing with broader, more generalized EHR vendors including Epic and athenahealth in specific specialty medical practice segments.
FOR QUALIFIED INSTITUTIONAL AND ACCREDITED INVESTORS ONLY: Under federal securities laws, private market investments on this platform are available exclusively to Institutional and Accredited Investors. Verification of status required before investing. Private investments involve significant risks including illiquidity, potential loss of principal, and limited disclosure requirements. "Augment" refers to Augment Markets, Inc. and its affiliates. Augment Markets, Inc. is a technology company offering software and data services, not a bank or financial institution. Cash Accounts are provided by Modern Treasury Corp. financial institution partners and through Augment's technology. Augment does not act as a money services business, provide money transmission, or serve as a custodian of funds. Funds held in your Cash Account are not FDIC insured unless expressly disclosed. Full terms available in the Augment Cash Account Agreement. Brokerage services are offered through Augment Capital, LLC, an affiliated broker-dealer and member FINRA/SIPC. "Investment accounts" are not brokerage accounts and do not hold customer funds or securities. Investment advisory services are offered through Augment Advisors, LLC, an SEC-registered investment adviser. Registration with the SEC does not imply a certain level of skill or training. Neither Augment Advisors, LLC nor Augment Capital, LLC provide legal or tax advice; consult your attorney or tax professional regarding your specific situation. For additional information, please refer to Augment Advisors, LLC's Form ADV Part 2A (Firm Brochure) and FINRA BrokerCheck.
No news available for this company.
| Company | Valuation |
|---|---|
Open Neuralink Healthtech |
| $51.4B |
Open Isomorphic Labs Artificial Intelligence | $47.6B |
Open Devoted Health Healthtech | $27.4B |
Open Oura Healthtech | $15.4B |
Open OpenEvidence Artificial Intelligence | $12.8B |
Sign up with Augment to see the latest market activity.
